News - Bankruptcy Court Approves Settlement with NECC and Related Companies
Foley & Small is pleased to announce that a Massachusetts bankruptcy judge has approved a settlement of over $100 million with the New England Compounding Center, related entities and certain other defendants. The claims arose after NECC's tainted steroids were injected into patients throughout the U.S., including Indiana and Michigan. The settlement includes resolution of claims against UniFirst and Liberty Industries. As was detailed in initial settlement filings, NECC partners Barry Cadden, Lisa Cadden, Carla Conigliaro and Greg Conigliaro will pay $47.5 million into the settlement fund.
Foley & Small represents more than 90 persons or their survivors who received the fungal laden injectable steroids.
St. Jude Medical Defibrillator Recall
FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
NECC Second Payments Expected This Summer
Tort Trustee Reports Payment Expectation at MDL Status Conference
Final NECC Victims' MDL Payments Due By Summer
The second and final payments to victims of the 2012 fungal meningitis outbreak should come this summer and the underlying court case should be nearing final resolution by August.
Cadden Guilty in NECC Criminal Trial
NECC owner Barry Cadden guilty on racketeering and fraud claims
What is Mass Tort Litigation?
Often seen with defective drugs or medical implants.